Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynectics Regulatory News (SNX)

Share Price Information for Synectics (SNX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 192.50
Bid: 190.00
Ask: 195.00
Change: 0.00 (0.00%)
Spread: 5.00 (2.632%)
Open: 192.50
High: 192.50
Low: 192.50
Prev. Close: 192.50
SNX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

6 Jun 2006 07:02

Synexus Clinical Research PLC06 June 2006 Synexus Clinical Research Plc ("the Company") Directorate change Synexus Clinical Research Plc is pleased to announce the appointment of MalcolmHughes (aged 52) as Non-Executive Director with immediate effect. Malcolm is currently Chief Executive of Greenman Group plc ("Greenman"), aprivate industrial company which supplies printer cartridges to European officesupplies distributors from its manufacturing base in Bulgaria. Prior toGreenman, he was Chief Executive of Oasis Healthcare Plc for four years duringwhich Oasis grew from a small regional business to become the leading dentalpractice owner/operator in the UK with turnover of over £70m. His previousexperience includes senior management roles at Chloride Group plc, LadbrokeGroup plc and Management Consulting Group plc. Commenting on the appointment, Michael Fort, chief executive of Synexus said : " I am delighted to welcome Malcolm to the Synexus board. He brings with himconsiderable knowledge and expertise, not only within the healthcare industrybut also particular experience of business operations within the emergingeconomies of Eastern Europe where Synexus has established a foothold and fromwhich we aim to expand rapidly. We look forward to benefiting from hiscontribution to the development and implementation of our growth strategy." Malcolm Hughes commented: "I am delighted to be joining Synexus at a time when it is seeking to build onits recent AIM flotation through expansion of its operations in the UK andinternationally. Its unique business model offers a strong proposition to globalpharmaceutical companies as they aim to develop more cost-effective methods oftrialling new drug treatments." Additional Information The following is a complete list of Mr Hughes' directorships as required underSchedule 2(g) of the AIM Rules: Current Previous in last 5 yearsGreenman Group plc Oasis Healthcare PlcGreenman UK Limited Oasis Dental Care LimitedGreenman Europe BV The Dencare Management Group LimitedK2 Supplies Limited Dencare Management LimitedPaprika Services Limited Dencare Financial Services LimitedBetforum UK Limited Dencare Developments Limited Dencare Implant Centres Limited Ora Dental Group Holdings Limited Ora Dental Group Limited Ora EBT Trustee Limited Inhoco 978 Limited Inhoco 979 Limited There is no further information required to be disclosed under Schedule 2(g) ofthe AIM Rules. For further information: Michael Fort, Chief Executive, Synexus Clinical Research PLC 01257 230 723 Zoe Biddick, Biddicks 020 7448 1000 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
4th Nov 20053:46 pmRNSOffer Extended
21st Oct 20055:14 pmRNSOffer Update
21st Oct 20052:10 pmRNSRule 8.3- Quadnetics Group
19th Oct 20052:45 pmRNSOffer Update
19th Oct 200512:11 pmRNSRule 8.3-Quadnetics Group PLC
19th Oct 200510:44 amRNSRule 8.3- Quadnetics Group
17th Oct 200512:15 pmRNSResult of EGM
14th Oct 20051:13 pmRNSRule 8.3- Quadnetics Group
12th Oct 200512:06 pmRNSRule 8.3- Quadnetics PLC
10th Oct 20055:38 pmRNSRule 8.3-Quadnetics Grp-Amend
10th Oct 200511:22 amRNSRule 8.3- Quadnetics Group
6th Oct 20053:48 pmRNSHolding in Company
5th Oct 200512:03 pmRNSRule 8.3-Quadnetics-Amendment
5th Oct 200511:27 amRNSRule 8.3-Quadnetics Group PLC
4th Oct 20059:32 amRNSRule 8.3-Quadnetics Group PLC
30th Sep 20056:06 pmRNSRecommended Offer
29th Sep 200511:55 amRNSRule 8.3- Quadnetics
23rd Sep 20057:01 amRNSRecommended Offer for Protec
15th Sep 20057:04 amRNSFinal Results
8th Sep 20054:10 pmRNSNotice of Results
5th Aug 200511:18 amRNSDirectorate Change
24th Jun 20058:54 amRNSAllotment of shares
21st Jun 200511:22 amRNSAllotment of Shares
23rd May 20054:19 pmRNSHolding in Company
17th May 20054:28 pmRNSDirector Shareholding
16th May 200511:42 amRNSIssue of Shares
4th May 20059:00 amRNSHoldings in Company
3rd May 20052:42 pmRNSDirector Shareholding
22nd Apr 200512:55 pmRNSAcquisition
11th Feb 20054:55 pmRNSHolding in Company
7th Feb 20052:14 pmRNSHolding(s) in Company
31st Jan 20057:01 amRNSInterim Results
24th Jan 20055:21 pmRNSNotice of Results
7th Jan 20054:13 pmRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.